Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biol Pharm Bull ; 47(1): 159-165, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38171775

RESUMEN

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are used to treat non-small cell lung cancer with EGFR mutations. However, first-generation erlotinib and second-generation afatinib often cause diarrhea, which may develop because of the association between EGFR-TKIs and the chloride channel or abnormalities in the intestinal microbiota due to disruption of the intestinal immune system. As reports on the effects of EGFR-TKIs on intestinal immunity are lacking, we aimed to determine whether the intestinal immune system is involved in the molecular effects of EGFR-TKIs on chloride channels using Caco-2 cells. Initially, we evaluated the association of chloride channels with α-defensin 5 (DEFA5), a marker of intestinal immunity. Erlotinib and afatinib significantly increased the extracellularly secreted DEFA5 level and autophagy-related 16-like 1 and X-box binding protein 1 transcript levels, indicative of enhanced granule exocytosis. Conversely, intracellular DEFA5 and Toll-like receptor 4 protein expression and tumor necrosis factor-α transcript levels decreased significantly, suggesting that Toll-like receptor 4 suppression repressed DEFA5 production. Furthermore, among the chloride channels, DEFA5 was found to significantly increase the transcript levels of cystic fibrosis transmembrane conductance regulators. These results indicate that DEFA5 plays a significant role in the mechanism of chloride channel-mediated diarrhea induced by EGFR-TKIs. Therefore, we successfully elucidated the potential host action of DEFA5 in cancer therapy for the first time.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas , Neoplasias Pulmonares , alfa-Defensinas , Humanos , Carcinoma de Pulmón de Células no Pequeñas/genética , Afatinib/efectos adversos , Clorhidrato de Erlotinib/efectos adversos , Neoplasias Pulmonares/metabolismo , Receptor Toll-Like 4/metabolismo , alfa-Defensinas/metabolismo , Inhibidores de Proteínas Quinasas/efectos adversos , Células CACO-2 , Cloruros/metabolismo , Receptores ErbB/metabolismo , Mutación , Diarrea/inducido químicamente , Canales de Cloruro/genética
2.
Chemosphere ; 170: 118-123, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27984775

RESUMEN

Cetylpyridinium chloride (CPC) is an antimicrobial agent used in many personal care products, with subsequent release into the environment. Since CPC is found at low concentrations in river and municipal wastewater, its influence on wildlife is of concern. Therefore, in this study, we used flow cytometry to examine the effects of sublethal concentrations of CPC on rat thymic lymphocytes in order to characterize the cellular actions of CPC at low concentrations in the presence and absence of H2O2-induced oxidative stress. CPC treatment increased the population of living cells with phosphatidylserine exposed on the outer surface of their plasma membranes (a marker of early stage apoptosis), elevated intracellular Zn2+ levels, and decreased the cellular content of nonprotein thiols. CPC also potentiated the cytotoxicity of H2O2. Our results suggest that, even at environmentally relevant sublethal concentrations, CPC exerts cytotoxic effects under oxidative stress conditions by increasing intracellular Zn2+ concentration and decreasing the cellular content of nonprotein thiols. These findings indicate that, under some in vitro conditions, CPC is bioactive at environmentally relevant concentrations. Therefore, CPC release from personal care products into the environment may need to be regulated to avoid its adverse effects on wildlife.


Asunto(s)
Cetilpiridinio/química , Peróxido de Hidrógeno/química , Linfocitos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Timocitos/efectos de los fármacos , Timo/efectos de los fármacos , Animales , Supervivencia Celular/efectos de los fármacos , Susceptibilidad a Enfermedades , Citometría de Flujo , Fluorescencia , Ratas , Compuestos de Sulfhidrilo/metabolismo , Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA